ACCENDRA HEALTH INC【ACH】Cash flow
Market cap
$214.52M
P/E ratio
| 2010/12 | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | - | - | - | - | 63 | 66 | 55 | 59 | 102 | 117 | 93 | 91 | 229 | 287 | 265 |
| Stock-based compensation | 6 | 6 | 6 | 6 | 8 | 11 | 12 | 12 | 16 | 16 | 20 | 25 | 21 | 23 | 27 |
| Cash from operations | 245 | 68 | 219 | 141 | -4 | 270 | 187 | 57 | 116 | 166 | 339 | 124 | 325 | 741 | 161 |
| Capital expenditures | -31 | -25 | -10 | -28 | -48 | -21 | -20 | -35 | -45 | -52 | -59 | -50 | -167 | -208 | -211 |
| Cash from investing | -37 | -34 | -191 | -57 | -317 | -36 | -25 | -417 | -816 | -52 | 80 | -54 | -1,804 | -137 | -117 |
| Payments for dividends | 45 | 51 | 56 | 61 | 63 | 64 | 63 | 63 | 48 | 5 | 1 | 1 | - | - | - |
| Repurchases of common stock | - | 16 | 15 | 19 | 10 | 20 | 71 | 5 | - | - | - | - | - | - | - |
| Proceeds from issuance of term debt, net | - | - | - | - | 548 | - | - | 250 | 696 | - | 155 | - | - | - | - |
| Repayments of term debt | - | - | - | - | 217 | - | - | 3 | 16 | 86 | 617 | 553 | 5 | 321 | 244 |
| Cash from financing | -142 | -58 | -68 | -82 | 279 | -124 | -142 | 273 | 701 | -130 | -379 | -129 | 1,497 | -417 | -268 |
| Free cash flow | |||||||||||||||
| FCF margin (%) |